Privia Health Group (NASDAQ:PRVA – Get Free Report)‘s stock had its “market outperform” rating restated by equities researchers at JMP Securities in a research note issued to investors on Monday,Benzinga reports. They currently have a $29.00 price objective on the stock. JMP Securities’ target price would indicate a potential upside of 24.33% from the company’s […]

Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at William Blair in a research note issued on Monday,RTT News reports. MRUS has been the topic of a number of other research reports. Needham & Company LLC reissued a “buy” rating and issued a $83.00 price objective on shares […]

Lazard (NYSE:LAZ – Get Free Report)‘s stock had its “market outperform” rating restated by analysts at JMP Securities in a research note issued on Monday,Benzinga reports. They presently have a $55.00 price target on the asset manager’s stock. JMP Securities’ price target would suggest a potential upside of 40.29% from the company’s previous close. LAZ […]